Expertise in
11
conditions

Elif I. Ekinci

St Vincent's Hospital Melbourne
Fitzroy, VIC, AU 
Expertise in
11
conditions
St Vincent's Hospital Melbourne
Fitzroy, VIC, AU 

Overview

Elif Ekinci practices practicing medicine in Fitzroy, Australia.

Ms. Ekinci is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Diabetic Nephropathy, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Wilson Disease, and Colonoscopy.

She is actively involved in clinical research, co-authoring 224 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

St Vincent's Hospital Melbourne
Fitzroy, VIC, Australia
Other Locations
300 Waterdale Road, Heidelberg Heights, VIC 3081, Australia
145 Studley Road, Heidelberg, VIC 3084, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drug: Fenofibrate
Study Phase: Phase 3
View 1 Less Clinical Trial

224 Total Publications

Survodutide Once Weekly for the Treatment of Adults with Obesity.
Survodutide Once Weekly for the Treatment of Adults with Obesity.
Journal: The New England journal of medicine
Published: June 08, 2026

Frequently Asked Questions about Elif I. Ekinci

Is Elif I. Ekinci a top-rated expert for Diabetic Nephropathy?

MediFind is an objective health platform that identifies experts based on real-world data. Elif I. Ekinci is classified as an Elite expert for Diabetic Nephropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Elif I. Ekinci participate in research or clinical trials?

Yes. Elif I. Ekinci has published 224 articles and abstracts on conditions like Diabetic Nephropathy. You can view a list of Elif I. Ekinci's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ekinci's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile